Zacks Small Cap Research on MSN
LNTH: Lantheus closes SPECT sale
By John Vandermosten, CFA NASDAQ:LNTH READ THE FULL LNTH RESEARCH REPORT As 2026 begins, we are updating investors on Lantheus Holdings, Inc. (NASDAQ:LNTH), highlighting several recent developments.
BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians ...
Cornell University and The General Hospital Corp. (Massachusetts General Hospital) have synthesized conjugates comprising a targeting moiety covalently linked to a radiolabeled metal chelator through ...
SHINE acquires Billerica manufacturing facility and established SPECT product portfolio, expanding leadership in nuclear ...
BEDFORD, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc., the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback